“…CD34 + fibrocytes appear to be constitutive elements of the connective tissue in a multitude of anatomical sites, such as the skin [12], the breast [3,6], the gastrointestinal tract [2,14,15], and the cervix [4]. In all of the aforementioned locations, the stroma of invasive carcinomas discloses a reduction or complete loss of CD34 + fibrocytes paralleled by the occurrence of a-SMApositive myofibroblasts [2,3,4,6,12,17]. In addition to their function as matrix-producing [5,8] and antigenpresenting cells [7], CD34 + fibrocytes secrete plateletderived growth factor (PDGF) [10], the receptor of which, c-kit (CD117), a protein receptor with tyrosine kinase activity, is structurally identical to that of stem cell factor (SCF).…”